The Swiss Biotech Day, hosted by the Swiss Biotech Association, stands as one of Europe’s leading biotechnology conferences. With a global reputation, last year’s event drew over 1,800 participants from 44 countries. In 2024, the conference will once again …
NEW YORK, NY – From March 18th to March 21st, 2024, Midtown New York City hosted the 96th Annual DCAT Week, renowned as one of the world’s largest and most prestigious business events in the pharmaceutical industry. Over four days, …
Join Our Founder and CEO @ DCAT Week
What: DCAT Member Company Announcement Forum
When: 10:36-10:43AM, on Monday March 18, 2024
Where: InterContinental Barclay, Grand Ballroom (2nd Floor)
Porton Pharma Solutions Ltd (hereinafter referred to as Porton or the Company) …
Porton Pharma Solutions Ltd. is thrilled to announce its commitment to climate action by joining the Science Based Targets initiative (SBTi). By aligning our emissions reduction targets with the Paris Agreement goals on limiting global warming to 1.5°C, we aim …
Farewell to 2023, and WE are Sailing forward to 2024
Year-end Review for 2023
Throughout 2023, despite myriad challenges, Porton stood united, striving, and collaborating as one Team.
We are committed to developing our core CDMO business, continuously improve the …
The Pharma Crystallization Summit (PCS) is held annually to bring together developers of new medicines with crystallization challenges and the crystallization experts (solution providers) in the industry and academia. PCS programs are designed to stimulate in-depth discussions on common and/or …
The Pharma Crystallization Summit (PCS) is held annually to bring together developers of new medicines with crystallization challenges and the crystallization experts (solution providers) in the industry and academia. PCS programs are designed to stimulate in-depth discussions on common and/or …
Porton Pharma Solutions Ltd. is glad to announce that it scored 38 (out of 100) in the 2023 S&P Global Corporate Sustainability Assessment reflecting an improvement of 9 points based on the 2023 methodology over the last year, where scores …
Porton Pharma Solutions has just opened its new drug development facility in Cranbury, New Jersey, operated under its US subsidiary J-STAR Research. With over 40,000 square feet of floor space, this facility is customer built to provide world-leading services in …
In order to thoroughly implement General Secretary Xi Jinping’s important exposition on the development of digital economy, his spirit of sending congratulatory letters to the Smart China Expo three times, his vital instruction of “Continue to host high-standard Smart …
Join us for a Journey of Innovation at J-STAR Research, Inc.’s Cranbury Open House!
🗓 September 6th & 7th, 4 PM – 6 PM
📍 2 Clarke & 6 Cedarbrook, Cranbury, NJ
Witness cutting-edge R&D and advanced manufacturing at our …
Dear valued customers and partners,
We would like to extend our gratitude for your continuous support towards Porton Pharma Solutions Ltd. In order to further enhance the company’s brand recognition, adapt to our global development strategy, improve communication efficiency, and …
